By now you've heard plenty of buzz about GLP-1 medications like Ozempic, Wegovy and Zepbound
4), particularly observed in thyroid cancer, indicates cancer development [75], given its role as a tumor marker in medullary thyroid neoplasia [86]
In contrast, a small set of nutrient-dense categories, most notably yogurt, show directionally positive changes, according to the authors
Jason Murphy, Head of Pharmacy at Chemist4U The bottom line Oral GLP-1s are delivering significant weight loss results in clinical trials, with many patients achieving the kind of weight reduction that can meaningfully improve long-term health
BPC 157, or Body Protection Compound 157, is a synthetic peptide composed of 15 amino acids
Tirzepatide (Zepbound), a dual GLP-1/GIP receptor agonist, represents a newer agent with robust weight loss efficacy